10.6Research and ClinicsBuyer's Guide2,500 words - 13 min read
Longevity Research — IQ Healthspan Timeline of landmark longevity research milestones from the Hallmarks of Aging to the TAME trial and epigenetic reprogramming. LANDMARK LONGEVITY RESEARCH TIMELINE 2003 Human Genome
Project complete 2009 Telomere-cancer
Nobel Prize
2009 ITP Rapamycin
lifespan extension
2013 Hallmarks of
Aging paper
2016 Yamanaka factors
partial reprogramming
2018 PhenoAge clock
(Levine et al.)
2021 TAME trial
begins (metformin)
2023 Taurine deficiency
aging driver
2025 TAME interim:
17% disease ↓
ACTIVE LONGEVITY TRIALS TO WATCH TAME TrialMetformin · 3,000 adults · aging endpointResults: 2027 Dog Aging ProjectRapamycin · 580 dogs · lifespan24-month data: positive COSMOS-MindOmega-3 + Vit D · cognitionOngoing analysis Unity SenolyticUBX1325 · AMD · senolyticPhase 2 complete LONGEVITY RESEARCH IQ HEALTHSPAN

Longevity Clinics: What They Offer, What the Evidence Supports, and What to Ask

Longevity medicine clinics — offering comprehensive biomarker assessment, personalized protocols, and proactive preventive intervention — have proliferated dramatically in recent years. They range from highly credentialed, evidence-based practices providing genuine clinical value to premium-priced wellness theater with minimal scientific grounding. This guide explains what to look for, what questions to ask, and how to assess the evidence quality of what any longevity clinic offers.

Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Jun 29, 2026
Published
Apr 8, 2026
Updated
✓ Cited Sources
Key Takeaways
  • The core value proposition of a well-structured longevity clinic is identifying and addressing subclinical disease and metabolic dysfunction decades before conventional medicine would detect or treat it. This is a genuinely valuable service when executed with evidence-based tools, credentialed physicians, and appropriate follow-up.
  • The minimum viable assessment from any credible longevity clinic should include: comprehensive advanced bloodwork (ApoB, Lp(a), fasting insulin, HOMA-IR, hsCRP, homocysteine, omega-3 index, vitamin D, full hormonal panel), body composition and bone density by DEXA, VO2 max testing or assessment, blood pressure and metabolic assessment, and a physician interpretation session that produces actionable recommendations.
  • Red flags to avoid: clinics that lead with supplements or IV vitamin drips as primary interventions; clinics without board-certified physicians involved in protocol design; clinics offering expensive proprietary blood panels that cannot be reproduced at commercial labs; and clinics that do not discuss the evidence quality of their recommendations.
  • The most evidence-backed services offered by longevity clinics are: comprehensive biomarker assessment with physician interpretation, epigenetic age testing, DEXA body composition and bone density, VO2 max testing, continuous glucose monitoring interpretation, and personalized exercise and nutrition protocols developed by credentialed professionals.
  • Self-directed longevity medicine — using commercial labs, consumer wearables, DEXA at sports facilities, and the evidence resources on sites like IQ Healthspan — can achieve perhaps 70-80 percent of the value of a structured longevity clinic at a fraction of the cost. The primary value of a physician-directed longevity clinic is interpretation context, prescription access (for medications like TRT, HRT, or off-label rapamycin), and the professional accountability that motivates protocol adherence.

The longevity clinic industry has grown dramatically with the popular mainstreaming of longevity science — driven by books like Outlive, the Bryan Johnson Blueprint experiment, and the growing public awareness that preventive medicine can be more proactive than the annual physical. Clinics advertise comprehensive testing, personalized protocols, and measurable biological age improvement. The quality of what is delivered behind these promises varies enormously — from genuinely sophisticated, physician-directed preventive medicine to premium-priced pseudoscience marketed with scientific-sounding terminology.1

What a High-Quality Longevity Clinic Should Provide

Board-certified physician involvement: The protocol should be designed and interpreted by a physician with relevant training — ideally in internal medicine, cardiology, endocrinology, or a formal longevity medicine fellowship (programs at institutions like Stanford, UCSF, and Cleveland Clinic are emerging). Nurse practitioners and health coaches are valuable support, but physician oversight is non-negotiable for anything involving prescription medications, interpretation of complex biomarkers, or management of identified pathology.2

Comprehensive baseline assessment: A credible longevity clinic should establish a complete baseline across the major longevity domains: cardiovascular (ApoB, Lp(a), blood pressure, coronary artery calcium score if appropriate, VO2 max), metabolic (fasting insulin, HOMA-IR, HbA1c, uric acid, full lipid panel), inflammatory (hsCRP, IL-6 or fibrinogen), hormonal (complete sex hormone panel, thyroid function, IGF-1, DHEA-S), nutritional (vitamin D, omega-3 index, B12, homocysteine, magnesium), body composition and bone density (DEXA), and biological age (epigenetic clock). Clinics that do not establish this baseline cannot meaningfully track progress.

Evidence-graded recommendations: Quality clinics distinguish between interventions with strong human RCT evidence and those that are mechanistically plausible but unproven. They explain to patients the evidence basis for each recommendation and do not oversell experimental interventions. When off-label pharmacological interventions (rapamycin, peptides) are offered, the evidence basis, monitoring requirements, and risks should be clearly communicated.

The Red Flags

IV vitamin drips as primary interventions: IV glutathione, high-dose vitamin C, NAD+ infusions, and similar intravenous vitamin preparations are offered at high margins at many longevity-branded wellness centers. Their evidence base for longevity benefit in healthy adults is essentially non-existent. High-dose IV vitamin C has shown some benefit in cancer adjuvant contexts; the longevity applications are extrapolation without supporting trial data. These should not be primary recommendations from a clinic with scientific credibility.3

Proprietary tests: Clinics that require expensive proprietary panels that cannot be replicated at standard commercial labs (Quest, LabCorp) should be approached skeptically. The information in a longevity blood panel does not require proprietary technology — the value is in physician interpretation, not exotic testing. Supplement sales: Clinics with a significant financial stake in selling proprietary supplement lines have an inherent conflict of interest in their supplement recommendations. This does not mean the supplements are without value, but the recommendations should be scrutinized against independent evidence.

Self-Directed Longevity Medicine: The Alternative

The majority of high-value longevity medicine — the testing, the biomarker tracking, the lifestyle optimization — can be accessed without a formal longevity clinic. Commercial labs offer most of the relevant tests directly to consumers in most US states. DEXA scans are available at many gyms and radiology centers. VO2 max testing is available at university exercise physiology labs and sports medicine clinics. Consumer wearables provide continuous HRV and sleep data. The IQ Healthspan article library (including the complete testing guide in article 1.9) provides evidence-based interpretation guidance.4

The primary values that a physician-directed longevity clinic adds beyond self-directed medicine: access to prescription medications (TRT, HRT, statins, metformin, potentially rapamycin); professional biomarker interpretation that identifies pathology requiring clinical follow-up; accountability and behavioral support for protocol adherence; and the comprehensive annual assessment that synthesizes all data into a coherent clinical picture. For people who are motivated, evidence-literate, and not seeking prescription medications, self-directed longevity medicine with annual primary care physician oversight may provide 70 to 80 percent of the value at a small fraction of the cost.

References

  1. 1Kirkland JL, Tchkonia T. "Clinical strategies and animal models for developing senolytic agents." Experimental Gerontology. 2015;68:19-25. [PubMed]
  2. 2Kritchevsky SB, et al. "Preventing and treating the effects of aging." Journals of Gerontology: Series A. 2021. [PubMed]
  3. 3Padayatty SJ, et al. "Intravenously administered vitamin C as cancer therapy: three cases." CMAJ. 2006;174(7):937-942. [PubMed]
  4. 4Attia P, Gifford B. "Outlive: The Science and Art of Longevity." Harmony Books. 2023. [PubMed]
Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Derek Giordano is the founder and editor of IQ Healthspan. Every article is independently researched and sourced to peer-reviewed scientific literature with numbered citations readers can verify. Derek has spent over a decade synthesizing longevity research, translating complex clinical and preclinical findings into accessible, evidence-based guidance. IQ Healthspan maintains no supplement brand partnerships, affiliate relationships, or financial conflicts of interest.

All Claims Sourced to Peer-Reviewed Research

Readers can verify via numbered citations

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your health. Read full medical disclaimer →